Christopher Andrés Guanoluisa Pérez
Christopher Andrés Guanoluisa Pérez has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Cristian Xavier Cushpa Pilco
General Dentist, Independent Practice, Riobamba, Ecuador
1 shared publication - Daniela Beatriz Ganchozo Peralta
Investigador independiente. Odontóloga general, Ecuador
1 shared publication - Diana Karina Arellano Garcia1 shared publication
- Jordy Calixto Arcentales Quijije1 shared publication
- Luis Fernando Loaiza Vivanco
General Dentist, Rural Practice, Loja, Ecuador
1 shared publication - Tupac Augusto Sarango González
General Dentist, Independent Practice, Saraguro, Loja, Ecuador
1 shared publication
Latest Publications
- Open Access
- 6 January 2026
- Published by Sapienza Grupo Editorial in Ibero-American Journal of Health Science Research
- Vol. 6 (1) , 340-352
Surgical versus conservative management of advanced-stage drug-related osteonecrosis of the jaw (MRONJ): a narrative review of cure rates
Introduction/objective: Medication-related osteonecrosis of the jaw (MRONJ) is an emerging iatrogenic condition in which optimum management of advanced stage disease is the subject of intense debate. This is a narrative review that evaluates the comparative effectiveness of surgical and conservative treatment strategies for advanced (stage 2/3) MRONJ including quantitative synthesis of success rates and identification of outcome-modifying adjuvant therapies. Methods: A systematic search of the literature was performed in PubMed, ScienceDirect and Cochrane Library for studies published January 2015 - February 2026 examining surgical and/or conservative management of stage 2/3 MRONJ. Empirical trend analysis and scientometric mapping of the evolution of therapy were carried out. Pooled success rates were calculated using random effect models. Results: We included 34 studies (n = 2,847 patients; 21 surgical, 7 conservative, 6 comparative studies). There were very high pooled complete resolution rates (74.8, 95% CI 68.3-81.2) with surgery that were in comparison much higher than with conservative management (28.4, 95% CI 19.7-37.1; OR 4.89, 95% CI 3.12-7.66; P < 0.001). Adjunctive platelet rich fibrin/concentrated growth factor application had a significant positive impact on surgical success (OR 2.34, 95% CI 1.56-3.51; P=0.002). Conservative monotherapy demonstrates* profound inadequacy **in case of stage 1 disease 91.3% of lesions fail to heal and 67% of lesions progress to advanced stages; in case of stage 2/3 patients conservative care the pooled complete resolution rate is only 22.7%. Conclusions: Contemporary evidence unequivocally shows surgical intervention to be superior to conservative management for advanced stage MRONJ with four-fold higher odds of complete resolution of disease. The historical treatment paradigm of positioning surgery as the last resort is no longer tenable; surgery with early definite resection, tension-free primary closure and adjuvant autologous platelet concentrates should be the standard of care for operable patients with stage 2/3 disease.
- 6 January 2026
- Published by Sapienza Grupo Editorial in Ibero-American Journal of Health Science Research
- Vol. 6 (1) , 340-352
Open AccessSurgical versus conservative management of advanced-stage drug-related osteonecrosis of the jaw (MRONJ): a narrative review of cure rates
Introduction/objective: Medication-related osteonecrosis of the jaw (MRONJ) is an emerging iatrogenic condition in which optimum management of advanced stage disease is the subject of intense debate. This is a narrative review that evaluates the comparative effectiveness of surgical and conservative treatment strategies for advanced (stage 2/3) MRONJ including quantitative synthesis of success rates and identification of outcome-modifying adjuvant therapies. Methods: A systematic search of the literature was performed in PubMed, ScienceDirect and Cochrane Library for studies published January 2015 - February 2026 examining surgical and/or conservative management of stage 2/3 MRONJ. Empirical trend analysis and scientometric mapping of the evolution of therapy were carried out. Pooled success rates were calculated using random effect models. Results: We included 34 studies (n = 2,847 patients; 21 surgical, 7 conservative, 6 comparative studies). There were very high pooled complete resolution rates (74.8, 95% CI 68.3-81.2) with surgery that were in comparison much higher than with conservative management (28.4, 95% CI 19.7-37.1; OR 4.89, 95% CI 3.12-7.66; P < 0.001). Adjunctive platelet rich fibrin/concentrated growth factor application had a significant positive impact on surgical success (OR 2.34, 95% CI 1.56-3.51; P=0.002). Conservative monotherapy demonstrates* profound inadequacy **in case of stage 1 disease 91.3% of lesions fail to heal and 67% of lesions progress to advanced stages; in case of stage 2/3 patients conservative care the pooled complete resolution rate is only 22.7%. Conclusions: Contemporary evidence unequivocally shows surgical intervention to be superior to conservative management for advanced stage MRONJ with four-fold higher odds of complete resolution of disease. The historical treatment paradigm of positioning surgery as the last resort is no longer tenable; surgery with early definite resection, tension-free primary closure and adjuvant autologous platelet concentrates should be the standard of care for operable patients with stage 2/3 disease.
- Open Access
- 1 July 2024
- Published by Sapienza Grupo Editorial in Ibero-American Journal of Health Science Research
- Vol. 4 (2) , 297-304
Effectiveness of contemporary surgical approaches and prosthetic rehabilitation in the management of ameloblastoma: a narrative review of functional and aesthetic outcomes
Ameloblastoma, a benign yet aggressive odontogenic tumour poses significant challenges in management due to its potential for recurrence and impact on oral functionality and aesthetics. Effective treatment necessitates a combination of surgical resection, bone reconstruction, and prosthetic rehabilitation. This review aims to evaluate contemporary surgical approaches and prosthetic rehabilitation strategies for managing ameloblastoma, focusing on functional and aesthetic outcomes to enhance patient recovery and quality of life. A narrative review was conducted using scholarly databases, incorporating articles published in English from 2013 to 2023. Studies were selected based on their focus on surgical approaches and prosthetic rehabilitation outcomes. A systematic framework categorized surgical techniques (radical, conservative) and prosthetic methods (fixed, removable, or implant-supported). Radical segmental resection with sufficient safety margins emerged as the preferred surgical approach to minimize recurrence. Immediate reconstruction using autogenous bone grafts, particularly vascularized fibula free-flaps, demonstrated high success rates and improved quality of life. Implant-supported prosthetics showed enhanced functional and aesthetic recovery, with immediate implants yielding better survival rates. Technological advancements such as CAD/CAM and 3D printing improved surgical precision and patient outcomes. Contemporary surgical and prosthetic advancements significantly enhance the management of ameloblastoma. Integrating innovative techniques with long-term follow-up ensures optimal functional and aesthetic results, contributing to improved patient satisfaction and recovery.
- 1 July 2024
- Published by Sapienza Grupo Editorial in Ibero-American Journal of Health Science Research
- Vol. 4 (2) , 297-304
Open AccessEffectiveness of contemporary surgical approaches and prosthetic rehabilitation in the management of ameloblastoma: a narrative review of functional and aesthetic outcomes
Ameloblastoma, a benign yet aggressive odontogenic tumour poses significant challenges in management due to its potential for recurrence and impact on oral functionality and aesthetics. Effective treatment necessitates a combination of surgical resection, bone reconstruction, and prosthetic rehabilitation. This review aims to evaluate contemporary surgical approaches and prosthetic rehabilitation strategies for managing ameloblastoma, focusing on functional and aesthetic outcomes to enhance patient recovery and quality of life. A narrative review was conducted using scholarly databases, incorporating articles published in English from 2013 to 2023. Studies were selected based on their focus on surgical approaches and prosthetic rehabilitation outcomes. A systematic framework categorized surgical techniques (radical, conservative) and prosthetic methods (fixed, removable, or implant-supported). Radical segmental resection with sufficient safety margins emerged as the preferred surgical approach to minimize recurrence. Immediate reconstruction using autogenous bone grafts, particularly vascularized fibula free-flaps, demonstrated high success rates and improved quality of life. Implant-supported prosthetics showed enhanced functional and aesthetic recovery, with immediate implants yielding better survival rates. Technological advancements such as CAD/CAM and 3D printing improved surgical precision and patient outcomes. Contemporary surgical and prosthetic advancements significantly enhance the management of ameloblastoma. Integrating innovative techniques with long-term follow-up ensures optimal functional and aesthetic results, contributing to improved patient satisfaction and recovery.
- Open Access
- 1 March 2022
- Published by Fundacion Koinonia in Revista Arbitrada Interdisciplinaria de Ciencias de la Salud. Salud y Vida
- Vol. 6 (1) , 495-503
Uso de la medicina natural y tradicional en las clínicas de cirugía
Objetivo: Analizar la medicina natural y tradicional en las clínicas de cirugía de la UAO en UNIANDES. Método: estudio descriptivo observacional. Resultados: En el periodo 2018 y 2019, se realizaron varios estudios con medicina natural y tradicional a 180 pacientes que acudieron a las clínicas de cirugía de la UAO para realizarse exodoncias. En el presente análisis, se valoró la clínica postoperatoria basado en cuatro criterios: presencia de dolor, inflamación, herida cicatrizal e infección, de pacientes sometidos a tratamiento con medicina natural versus pacientes a los que no se aplicó ningún método complementario. Conclusión: Acorde al presente análisis y comparación, los fitofármacos proporcionan una amplia gama de evidencia del éxito clínico con su aplicación. Se avalan la efectividad de la Medicina Natural y tradicional en la cicatrización en cavidad oral, del mismo modo la regeneración tisular fue evidente gracias a las propiedades benéficas de las plantas y sus componentes activos.
- 1 March 2022
- Published by Fundacion Koinonia in Revista Arbitrada Interdisciplinaria de Ciencias de la Salud. Salud y Vida
- Vol. 6 (1) , 495-503
Open AccessUso de la medicina natural y tradicional en las clínicas de cirugía
Objetivo: Analizar la medicina natural y tradicional en las clínicas de cirugía de la UAO en UNIANDES. Método: estudio descriptivo observacional. Resultados: En el periodo 2018 y 2019, se realizaron varios estudios con medicina natural y tradicional a 180 pacientes que acudieron a las clínicas de cirugía de la UAO para realizarse exodoncias. En el presente análisis, se valoró la clínica postoperatoria basado en cuatro criterios: presencia de dolor, inflamación, herida cicatrizal e infección, de pacientes sometidos a tratamiento con medicina natural versus pacientes a los que no se aplicó ningún método complementario. Conclusión: Acorde al presente análisis y comparación, los fitofármacos proporcionan una amplia gama de evidencia del éxito clínico con su aplicación. Se avalan la efectividad de la Medicina Natural y tradicional en la cicatrización en cavidad oral, del mismo modo la regeneración tisular fue evidente gracias a las propiedades benéficas de las plantas y sus componentes activos.